Susan Billings Ph D

𝗖𝗼𝗺𝗽𝗮𝗻𝘆: Headquartered in Albany, NY with multi-national operations in 19 locations. Leader in contract research (CRO) and contract development manufacturing services (CDMO) for the pharmaceutical industry. 𝗧𝗲𝗻𝘂𝗿𝗲 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄: Provide strategic and tactical leadership of global commercial business development that drives double-digit YOY company growth and superior customer experience 𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄: Executive leadership of a matrixed global team of Business Development Sales Managers, Directors, Senior Directors and VP’s in securing contract awards up to hundreds of millions of dollars. PERFORMANCE • Since 2016, contributed to exceptional revenue and EBITDA growth through securing successful business contracts • Achieved double-digit YOY sales growth by combination of new customer business and expanding current customer business • Consistently exceeded sales profitability goals and objectives STRATEGY • In 2016, formulated and created backbone of AMRI’s Chemical Development & Manufacturing global strategic framework, which has become AMRI’s top focus for key strategic initiatives for investment, inorganic growth targeted “high value” selling, and increased brand awareness • Developed and implemented targeted selling of high value contracts that has directly increased ROI RECOGNITION • Recognized as top AMRI business development performer 2014 – 2019 as reflected in annual sales growth and booked business target attainment vs. sales goal. • Received “AMRI Leadership Award” for Exceptional Performance in Sales, Team Management, Operational Collaboration, and Operational results in 2018 and 2019

𝗨.𝗦. 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 & 𝗖𝗵𝗲𝗺𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗙𝗿𝗮𝗻𝗰𝗵𝗶𝘀𝗲 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆 𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄: Trained and led a highly talented team that prospected and successfully signed on new business deals and grew existing relationships across all segments including drug discovery, chemical development, and early clinical to late clinical stage & commercial drug substance API manufacturing valued up to hundreds of millions of dollars. • Exceeded 2016 sales plan substantially, contributing to AMRI’s double-digit revenue growth • Managed alliance initiatives and executed on the key account strategy developed in previous role for the company’s largest key accounts that generated several million dollars in annual revenue each • Negotiated business-level contracts and cultivated existing relationships that fueled business expansion • Successfully negotiated a Master Commercial Supply Agreement for a new chemical entity of a large pharmaceutical company with potential contract value of several million dollars

𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄: Promoted as a direct result of demonstrated strength driving business and negotiating multi-year/multimillion-dollar contracts to support drug discovery, chemical development, and clinical stage manufacturing stage programs • Negotiated, structured, and closed a strategic, 3-year, multi-million-dollar deal with a key pharmaceutical client • Received “Top Performer Business Development” award in 2015 for exceeding sales quota goal by 278% with a combination of large and emerging pharma new customer business

𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄: Recruited to manage and expand the Northeast and Midwest territories for Drug Discovery Services business. Responsibility increased to include the Chemical Development and Manufacturing Services business unit after 2 years. • Expanded the territory and secured several million dollars in new business, achieving 230% of goal for 2014 • Managed existing business of several million dollars and secured several million more dollars in new business from developing the Midwest and Southeast territories • Signed a multi-million dollar, 2-year deal for a fully integrated ALS drug discovery program with a leading biotechnology company

𝗖𝗼𝗺𝗽𝗮𝗻𝘆: Privately held drug discovery contract research organization with operations in Beijing, China that include in vitro biology and in vivo pharmacology, DMPK, and medicinal and contract chemistry services. 𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄: Led and managed business development for the U.S. East Coast, UK, and Scandinavia territory securing drug discovery business contracts before being actively recruited by AMRI. Managed 2 key accounts – large global pharmaceutical companies with committed business of several million dollars each.

𝗖𝗼𝗺𝗽𝗮𝗻𝘆: Top tier multinational pharmaceutical company providing healthcare solutions through prescription medicines, vaccines, biologic therapies, and animal health products 𝗞𝗲𝘆 𝗔𝗰𝗵𝗶𝗲𝘃𝗲𝗺𝗲𝗻𝘁: Received the “Global Procurement Top Performance” award for innovation and strategy for Merck’s Reagent Acquisition Program (RAP) 𝗧𝗲𝗻𝘂𝗿𝗲 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄: Served in multi-faceted role managing programs and projects that supported basic research, pre-clinical development, and procurement. 𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄: Led Merck’s Reagent Acquisition Program (RAP), a chemistry building block program designed to in source various synthetic intermediates to support the needs of medicinal/process chemists in Lead ID, Lead Optimization, and PCC space, managed a multi-million-dollar budget for the sourcing of 4,000 compounds from 10 vendors in 5 countries. • Expanded the RAP program to support early discovery programs ongoing at external Contract Research Organizations worldwide • Collaborated and led procurement strategy that saved several million dollars with the implementation of a tiered fee-for-service pricing model that delivered savings back to Merck, assured supply, and yielded sustainable profit margins for suppliers

𝗧𝗲𝗻𝘂𝗿𝗲 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄: Started as a Senior Research Scientist in Medicinal Chemistry-Oncology and subsequently transitioned to Business Development and Alliance Management. • Preparation and management of company agreements (Non-Confidential Disclosure Agreements, Material Transfer Agreements, Consultancy Agreements); monitored all agreements to ensure compliance with payment schedules, reporting and renewal provisions. • Project alliance and management activities between TetraLogic and external research collaborators that included study protocols and timelines, budgets, required meetings/teleconferences and execution of studies. • Interacted with Institutional Technology Transfer Offices and negotiated required academic agreements. • Preparation and management of project plans and financial projections/budget forecasting and YTD spend • Performed Competitive Intelligence Analyses on global pharma companies, pipelines, products and deal structures. • Analyzed and interpreted scientific and technical data to identify trends for broader project scope and proof of concept. .

𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄: Synthesized potential drug candidates for biological testing, working within a team of five chemists. • Analyzed biological data and assisted in decision process for scale up of biologically active molecules. • Designed and implemented synthetic strategies to access a series of novel analogs. • Delivered required amounts of scale up compounds under very strict deadlines. • Presented research progress and relevant literature at weekly group meetings to colleagues and senior management. • Single point of contact for ordering laboratory chemicals and supplies while maintaining budget guidelines. • Negotiated with various suppliers on pricing plans for TetraLogic for fine chemicals, solvents, laboratory supplies.

𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄: Competitive internship (two students selected for Medicinal Chemistry Department). • Successfully completed synthesis and purification of complex molecules that target the NR2B receptor for patients suffering from chronic pain. • Project team consisted of 25 chemists; worked closely within a group of four chemists. • Presented research progress at biweekly meetings using PowerPoint, Excel, ChemDraw.

𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄: Cardiovascular System focus • Worked closely in team of five chemists to synthesize Factor Xa inhibitors for anti-coagulant studies. • Delivered a 45-minute presentation to Chemistry Department at the completion of internship.